Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12779/5949
DC FieldValueLanguage
dc.contributor.authorArena, Giadaen_us
dc.contributor.authorZill, Nen_us
dc.contributor.authorSalvadori, Jessicaen_us
dc.contributor.authorGirard, Nen_us
dc.contributor.authorMann, Aen_us
dc.contributor.authorTaddei, Maurizioen_us
dc.date.accessioned2021-03-30T15:56:20Z-
dc.date.available2021-03-30T15:56:20Z-
dc.date.issued2011-
dc.identifier.issn1523-7060en_US
dc.identifier.urihttp://hdl.handle.net/20.500.12779/5949-
dc.description21423en_US
dc.description.abstractConvenient accesses to enantiomerically pure 2-, 2,3-, 2,6-, 2,3,6-substituted piperidines and 1,4-substituted indolizine are described. At first, indium-mediated aminoallylation and -crotylation of aldehydes with (R)-phenylglycinol or (1R,2S)-1-amino-2-indanol gave homoallylamines with high stereocontrol. Then, these products, submitted to a Rh(I)-catalyzed hydroformylative cyclohydrocarbonylation, afforded perhydrooxazolo [3,2-a]piridines whose oxazolidines are opened with nucleophiles. Finally, the removal of the chiral auxiliaries delivered the enantiomerically pure piperidines.en_US
dc.language.isoenen_US
dc.relationNoneen_US
dc.relation.ispartofORGANIC LETTERSen_US
dc.titleCyclohydrocarbonylation-based strategy toward poly- susbtituted piperidinesen_US
dc.typeArticleen_US
dc.identifier.doi10.1021/ol200557ren_US
dc.identifier.scopus2-s2.0-79955578898en_US
dc.identifier.isiWOS:000289956700039en_US
dc.relation.volume13en_US
dc.description.firstpage2294en_US
dc.description.lastpage2297en_US
dc.description.thirdmissionNot applicableen_US
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeArticle-
item.fulltextNo Fulltext-
crisitem.author.orcid0000-0001-8660-7580-
Appears in Collections:Publications
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.